首页/数据集/DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.. DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.

DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.. DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.

NIAID Data Ecosystem2026-03-13 收录

表观遗传药物协同作用

肝细胞癌治疗

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA836561 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

应用场景：

创建时间：

2022-05-09

肝细胞癌治疗

分子靶向药物

Background & Aims: Intermediate hepatocellular carcinoma (HCC) treatment has become complicated due to the development of various molecular-targeted agents (MTAs). We aimed to determine whether the ad

NIAID Data Ecosystem90

Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma

立体定向体部放疗

肝细胞癌治疗

The feasibility of marker-less stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) has not yet been established, and, thus, was examined in the present study. We retrospectively i

Figshare2021-11-17 更新50

Supporting data for “Anti-Stanniocalcin 1 antibody as a potential therapeutic strategy for hepatocellular carcinoma and liver fibrosis"

肝细胞癌治疗

肝纤维化研究

Data collected for the thesis entitled "Anti-Stanniocalcin 1 antibody as a potential therapeutic strategy for hepatocellular carcinoma and liver fibrosis". Various types of data were involved, includi

DataCite Commons2023-09-11 更新30

Supplementary Material for: Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients

肝细胞癌治疗

并发症分析

Introduction: Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is considered a safe and minimally invasive procedure. We previously reported that the mortality and compli

DataCite Commons2020-08-26 更新70

Unresectable Hepatocellular Carcinoma Treatment Market

肝细胞癌治疗

医疗市场分析

Report of Unresectable Hepatocellular Carcinoma Treatment Market is currently supplying a comprehensive analysis of many things which are liable for economy growth and factors which could play an impo

IMR REPORTS40

DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.. DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells.

资源简介：

相关数据集